Biopharmaceuticals, also known as biologics, are a class of drugs that are produced using living cells or organisms. They are typically large, complex molecules, such as proteins, nucleic acids, or antibodies, that are used to treat a variety of diseases, including cancer, autoimmune disorders, および感染症. Biopharmaceuticals are produced using biotechnology techniques, such as genetic engineering, fermentation, and cell culture. They are designed to target specific molecules or cells in the body, and may be more effective and have fewer side effects than traditional small molecule drugs. 最新の推定によると, the global biopharmaceuticals market is set to achieve an incremental growth of USD 283.5 百万, ほぼ年平均成長率で加速 7.99% 予測期間中 2023-2029.

レポートは市場規模と成長をカバーしています, セグメンテーション, 地域内訳, 競争環境, trends and strategies for global biopharmaceuticals market. 利害関係者が現在の市場機会を活用できるように、市場の定量的な分析を提供します。. このレポートはまた、市場動向と主要な競合他社のアプローチに基づいて、機会と戦略の上位セグメントを特定します。.

この業界レポートは、世界市場の市場推定と予測を提供します。, 続いて製品タイプの詳細な分析, 応用, と地域. The global market for biopharmaceuticals can be segmented by product type: モノクローナル抗体, recombinant growth factors, purified proteins, 組換えタンパク質, recombinant hormones, ワクチン, recombinant enzymes, cell and gene therapies, synthetic immunomodulators, その他. 研究によると, the monoclonal antibodies segment had the largest share in the global biopharmaceuticals market. Biopharmaceuticals market is further segmented by application: 腫瘍学, autoimmune disorders, inflammatory and infectious diseases, metabolic disorders, other therapeutic, neurological diseases, 心血管疾患, hormonal disorders. の 2022, the inflammatory and infectious diseases segment made up the largest share of revenue generated by the biopharmaceuticals market. 地域に基づく, the biopharmaceuticals market is segmented into: 北米, ヨーロッパ, アジア太平洋地域, もの (中東とアフリカ), ラテンアメリカ. このうち, 北米は最も高い収益を生み出す国でした。 2022.

The monoclonal antibodies market is further segmented into anti-cancer monoclonal antibodies, anti-inflammatory monoclonal antibodies, その他. The latest analysis indicates that the anti-cancer monoclonal antibodies segment occupied the largest share of this market in 2022 今後数年間で最も高い需要が見込まれる. さらに, the recombinant hormones market has been categorized into recombinant human growth hormones, recombinant insulin, その他. 世界的に, the recombinant insulin segment made up the largest share of the biopharmaceuticals market. The vaccines market is further divided into recombinant vaccines, convectional vaccines. The recombinant vaccines segment was the largest contributor to the global biopharmaceuticals market in 2022. The recombinant growth factors market is further segmented into erythropoietin, granulocyte colony stimulating factor. The latest analysis indicates that the erythropoietin segment occupied the largest share of this market in 2022 今後数年間で最も高い需要が見込まれる. さらに, the recombinant proteins market has been categorized into serum albumin, amyloid protein, defensin, transferrin. 世界的に, the transferrin segment made up the largest share of the biopharmaceuticals market.

市場セグメンテーション
製品タイプ別: モノクローナル抗体, recombinant growth factors, purified proteins, 組換えタンパク質, recombinant hormones, ワクチン, recombinant enzymes, cell and gene therapies, synthetic immunomodulators, その他
用途別: 腫瘍学, autoimmune disorders, inflammatory and infectious diseases, metabolic disorders, other therapeutic, neurological diseases, 心血管疾患, hormonal disorders
地域別: 北米, ヨーロッパ, アジア太平洋地域, もの (中東とアフリカ), ラテンアメリカ

The report also provides analysis of the key companies of the industry and their detailed company profiles including AbbVie Inc., Amgen Inc., Pfizer Inc., Novartis AG, Bristol Myers Squibb Company, Eli Lilly and Company, ジョンソン & ジョンソン, Novo Nordisk AS, GSK plc, F. Hoffmann-la Roche Ltd., Sanofi SA, Astrazeneca plc, とりわけ. このレポートでは, 市場の競争見通しを理解するために、主要なプレーヤーとその戦略を徹底的に分析します。.
*無料サンプルをリクエストして企業の完全なリストを入手してください

報告書の範囲
• To analyze and forecast the market size of the global biopharmaceuticals market.
• To classify and forecast the global biopharmaceuticals market based on product type, 応用, 領域.
• To identify drivers and challenges for the global biopharmaceuticals market.
• 合併などの競争展開を検討するため & 買収, 協定, コラボレーションとパートナーシップ, 等, in the global biopharmaceuticals market.
• To identify and analyze the profile of leading players operating in the global biopharmaceuticals market.

このレポートを選択する理由
• Gain a reliable outlook of the global biopharmaceuticals market forecasts from 2023 に 2029 シナリオ全体にわたって.
• 投資対象となる成長セグメントを特定する.
• 会社概要と市場データを通じて競合他社に先んじる.
• Excel 形式でのシナリオ全体の分析を容易にするための市場予測.
• 3ヶ月間の戦略コンサルティングとリサーチサポート.
• シングルユーザーライセンスに提供される印刷認証.